O'Shaughnessy Asset Management’s Precigen PGEN Stock Holding History

O'Shaughnessy Asset Management’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-17,719	Closed	-$26.9K	–	1527
2022 Q4	$26.9K	Buy	+17,719	New	+$30.5K	﹤0.01%	1291
2021 Q4	–	Sell	-3,635	Closed	-$18K	–	2133
2021 Q3	$18K	Sell	3,635 -1,142	-24%	-$6.57K	﹤0.01%	1988
2021 Q2	$31K	Sell	4,777 -11,038	-70%	-$77.1K	﹤0.01%	1726
2021 Q1	$109K	Hold	15,815	–	–	﹤0.01%	1161
2020 Q4	$161K	Buy	+15,815	New	+$103K	﹤0.01%	911
2020 Q1	–	Sell	-529	Closed	-$3K	–	1681
2019 Q4	$3K	Buy	+529	New	+$2.98K	﹤0.01%	1599

Other funds holding PGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

PCM

Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

O'Shaughnessy Asset Management's PGEN Position: Q1 2023 in Review

O'Shaughnessy Asset Management sold out of Precigen (PGEN) in Q1 2023, closing a stake of 17,719 shares — an estimated $26.9K sold.

O'Shaughnessy Asset Management first reported a position in PGEN in Q4 2019 and held it in 6 quarters. The position peaked at $161K in Q4 2020. 157 funds tracked by Wall St. Rank hold PGEN as of Q1 2023.

O'Shaughnessy Asset Management reported no remaining Precigen position as of Q1 2023 after selling out during the quarter.
O'Shaughnessy Asset Management sold 17,719 Precigen shares in Q1 2023, an estimated $26.9K.
O'Shaughnessy Asset Management first reported a position in Precigen in Q4 2019 and held it in 6 quarters.
O'Shaughnessy Asset Management's Precigen position peaked at $161K in Q4 2020.
157 funds tracked by Wall St. Rank held Precigen as of Q1 2023.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2023, filed 12 May 2023.